The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: Results of the American College of Surgeons Oncology Group Z0060 trial Academic Article uri icon

Overview

MeSH Major

  • Carcinoma
  • Esophageal Neoplasms
  • Positron-Emission Tomography

abstract

  • Although 22% of eligible patients did not undergo esophagectomy, FDG-PET after standard clinical staging for esophageal carcinoma identified confirmed M1b disease in at least 4.8% (95% confidence interval: 2.2%-8.9%) of patients before resection. Unconfirmed PET evidence of M1 disease and regional adenopathy (N1 disease) led to definitive nonsurgical or induction therapy in additional patients.

publication date

  • March 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.jtcvs.2006.09.079

PubMed ID

  • 17320575

Additional Document Info

start page

  • 738

end page

  • 45

volume

  • 133

number

  • 3